pe
pep-05367 v1 CC-BY-SA-4.0

P32 cancer-fighting peptide

A short protein fragment studied in the lab for its ability to fight cancer cells; experimental, not yet an approved drug.

statuscomputed targetANTICANCER length47 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.646
avg pLDDT85.1
ranking score0.810
STRUCTURE · PEP-05367 × ANTICANCER
ranking0.810
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence47 aa
15101520253035404547
KPNGYGGSGNHWVHCG AGIVGGALIGAIGGPW SAVAGGISGGFASCH
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.8098074793815613 boltz-2
3-letter notation
Lys-Pro-Asn-Gly-Tyr-Gly-Gly-Ser-Gly-Asn-His-Trp-Val-His-Cys-Gly-Ala-Gly-Ile-Val-Gly-Gly-Ala-Leu-Ile-Gly-Ala-Ile-Gly-Gly-Pro-Trp-Ser-Ala-Val-Ala-Gly-Gly-Ile-Ser-Gly-Gly-Phe-Ala-Ser-Cys-His
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). P32 cancer-fighting peptide (pep-05367, v1). PeptideModel. https://peptidemodel.com/card/pep-05367
@peptide{pep05367,
  sequence = {KPNGYGGSGNHWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
references 1 papers
[1]
Synthesis of Trypsin-Resistant Variants of the Listeria -Active Bacteriocin Salivaricin P
O'Shea E; O'Connor P; Cotter P; Ross R; Hill C Applied and Environmental Microbiology 2010
source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use